Solid Tumors Panels

Indicated for the detection of variants that are targets for cancer therapeutic or prognosis
  • Indicated for the detection of variants that are targets for cancer therapeutic or prognosis.
  • Covers hotspots, full exons or the entire gene within 26 of the most relevant cancer genes involved in solid tumors.
  • Offers at least 94% sensitivity and 100% specificity and positive predictive values for SNVs and indels with ≥3% and 5% variant allele frequency, respectively.
  • Can be performed on DNA extracted from formalin-fixed, paraffin-embedded (FFPE).

Genes tested in the assay

AKT1 ALK APC BRAF CDH1 CTNNB1 EGFR ERBB2 FBXW7 FGFR2 FOXL2 GNAQ GNAS KIT KRAS MAP2K1 MET MSH6 NRAS PDGFRA PIK3CA PTEN SMAD4 SRC STK11 TP53